SCOPUS 정보 검색 플랫폼

Expert Opinion on Drug Safety

Volumn 10, Issue 1, 2011, Pages 3-8

Managing the teratogenic risk of thalidomide and lenalidomide: An industry perspective

(3) Bwire, Robert a Freeman, John a Houn, Florence a

a CELGENE CORPORATION (United States)

Author keywords

lenalidomide; pregnancy prevention; risk management; thalidomide

Indexed keywords

LENALIDOMIDE; THALIDOMIDE;

CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; FETUS MALFORMATION; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HEALTH PROGRAM; HIGH RISK BEHAVIOR; HUMAN; PREGNANCY; PRENATAL EXPOSURE; REVIEW; RISK MANAGEMENT; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; CONTRACEPTION; DRUG INDUSTRY; FEMALE; HUMANS; PREGNANCY; RISK MANAGEMENT; THALIDOMIDE;

EID: 78650508619 PISSN: 14740338 EISSN: None Source Type: Journal
DOI: 10.1517/14740338.2011.527331 Document Type: Review

Times cited : (29)

References (17)

1
- 73849170526
- The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies
- Mellin G, Katzenstein M. The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies. N Engl J Med 1962;267:1184-92
- (1962) N Engl J Med , vol.267 , pp. 1184-1192
- Mellin, G.¹ Katzenstein, M.²

2
- 0000962444
- Lenz W. Kindliche Missbildungen nach Medilamenteinnahme wahrend der Graviditatt? Dtsch Med Wochenschr 1961;86:2555
- (1961) Kindliche Missbildungen Nach Medilamenteinnahme Wahrend der Graviditatt? Dtsch Med Wochenschr , vol.86 , pp. 2555
- Lenz, W.¹

3
- 47349113508
- Thalidomide and congenital abnormalities
- McBride WG. Thalidomide and congenital abnormalities. Lancet 1961;2:1358
- (1961) Lancet , vol.2 , pp. 1358
- McBride, W.G.¹

4
- 0001145253
- Thalidomide and malformations in Liverpool
- Smithells RW. Thalidomide and malformations in Liverpool. Lancet 1962;1:1270-3
- (1962) Lancet , vol.1 , pp. 1270-1273
- Smithells, R.W.¹

5
- 2542593141
- Thalidomide
- DOI 10.1016/S0140-6736(04)16308-3, PII S0140673604163083
- Franks ME, Macpherson GR, Figg WD. Thalidomide. Lancet 2004;363:1802-11 (Pubitemid 38698386)
- (2004) Lancet , vol.363 , Issue.9423 , pp. 1802-1811
- Franks, M.E.¹ Macpherson, G.R.² Figg, W.D.³

6
- 0032922147
- S.T.E.P.S-: A comprehensive program for controlling and monitoring access to thalidomide
- Zeldis JB, Williams BA, Thomas SD, et al. S.T.E.P.S-: a comprehensive program for controlling and monitoring access to thalidomide. Clin Ther 1999;21:319-30
- (1999) Clin Ther , vol.21 , pp. 319-330
- Zeldis, J.B.¹ Williams, B.A.² Thomas, S.D.³

7
- 49749133938
- RevAssist-: A comprehensive risk minimization programme for preventing fetal exposure to lenalidomide
- Castaneda CP, Zeldis JB, Freeman J, et al. RevAssist-: a comprehensive risk minimization programme for preventing fetal exposure to lenalidomide. Drug Saf 2008;31:743-52
- (2008) Drug Saf , vol.31 , pp. 743-752
- Castaneda, C.P.¹ Zeldis, J.B.² Freeman, J.³

8
- 27644591608
- Properties of thalidomide and its analogues: Implications for anticancer therapy
- Teo SK. Properties of thalidomide and its analogues: implications for anticancer therapy. AAPS J 2005;7:E14-19
- (2005) AAPS J , vol.7
- Teo, S.K.¹

9
- 0342313474
- Teratogen update: Thalidomide: A review, with a focus on ocular findings and new potential uses
- DOI 10.1002/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y
- Miller MT, Stromland K. Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses. Teratology 1999;60:306-21 (Pubitemid 30265249)
- (1999) Teratology , vol.60 , Issue.5 , pp. 306-321
- Miller, M.T.¹ Stromland, K.²

10
- 25444519712
- Diagnostic considerations in the measurement of human chorionic gonadotropin in aging women
- DOI 10.1373/clinchem.2005.053595
- Snyder JA, Haymond S, Parvin CA, et al. Diagnostic considerations in the measurement of human chorionic gonadotropin in aging women. Clin Chem 2005;51:1830-5 (Pubitemid 41368173)
- (2005) Clinical Chemistry , vol.51 , Issue.10 , pp. 1830-1835
- Snyder, J.A.¹ Haymond, S.² Parvin, C.A.³ Gronowski, A.M.⁴ Grenache, D.G.⁵

11
- 21744457236
- Positive pregnancy tests in a nongravid, premenopausal woman due to hCG β-chain production by multiple myeloma
- DOI 10.1309/7BRD-M5A1-7XN3-QFKM
- Slone SP, Ahmed Z, Cole LA, et al. Positive pregnancy tests in a nongravid, premenopausal woman due to hCG beta-chain production by multiple myeloma. Am J Clin Pathol 2005;124:108-12 (Pubitemid 40944382)
- (2005) American Journal of Clinical Pathology , vol.124 , Issue.1 , pp. 108-112
- Slone, S.P.¹ Ahmed, Z.² Cole, L.A.³ Elin, R.J.⁴ Martin, A.W.⁵ Hezivg, R.H.⁶ Herzig, G.P.⁷ Miller, J.J.⁸

12
- 33645469813
- Thalidomide use in the US. Experience with pregnancy testing in the S.T.E.P.S programme
- Uhl K, Cox E, Rogan R, et al. Thalidomide use in the US. Experience with pregnancy testing in the S.T.E.P.S programme. Drug Saf 2006;29:321-9
- (2006) Drug Saf , vol.29 , pp. 321-329
- Uhl, K.¹ Cox, E.² Rogan, R.³

13
- 78650498340
- Volume 9A of the Rules Governing Medicinal Products in the European Union: the Guidelines on Pharmacovigilance for Medicinal Products for Human Use Food and Drug Administration. Title IX, the Food and Drug Administration Amendments Act of 2007
- Volume 9A of the Rules Governing Medicinal Products in the European Union: the Guidelines on Pharmacovigilance for Medicinal Products for Human Use Food and Drug Administration. Title IX, the Food and Drug Administration Amendments Act of 2007

14
- 78650450011
- Patient experience with RevAid a Canadian distribution program for lenalidomide. Abstract accepted for the10th ISoP Meeting
- Renaud C, Burtis J, Azzarrello D, Bwire R. Patient experience with RevAid, a Canadian distribution program for lenalidomide. Abstract accepted for the10th ISoP Meeting; Accra, Ghana; 2010
- Accra Ghana , vol.2010
- Renaud, C.¹ Burtis, J.² Azzarrello, D.³ Bwire, R.⁴

15
- 29144442476
- ICH Guideline. November
- ICH Guideline. E2E. Pharmacovigilance planning. November 2004
- (2004) E2E Pharmacovigilance Planning

16
- 77952075690
- Food and Drug Administration September
- Food and Drug Administration. Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments, and Proposed REMS Modifications, September 2009
- (2009) Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS) REMS Assessments and Proposed REMS Modifications

17
- 0028179836
- Thalidomide revisited
- DArcy PF, Griffin JP. Thalidomide revisited. Adverse Drug React Toxicol Rev 1994;13:65-7
- Adverse Drug React Toxicol Rev , vol.1994 , Issue.13 , pp. 65-67
- Darcy, P.F.¹ Griffin, J.P.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.